Clearline Capital’s Bausch Health BHC Stock Holding History

Clearline Capital’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-987,206	Closed	-$6.88M	–	144
2024 Q2	$6.88M	Buy	+987,206	New	+$7.47M	0.19%	58
2024 Q1	–	Sell	-1,167,343	Closed	-$9.36M	–	124
2023 Q4	$9.36M	Hold	1,167,343	–	–	0.57%	33
2023 Q3	$9.6M	Hold	1,167,343	–	–	0.82%	35
2023 Q2	$9.34M	Buy	1,167,343 +258,876	+28%	+$1.91M	0.54%	28
2023 Q1	$7.36M	Sell	908,467 -7,700	-0.8%	-$61.8K	1.11%	31
2022 Q4	$5.75M	Buy	916,167 +49,904	+6%	+$349K	1.03%	30
2022 Q3	$5.97M	Sell	866,263 -659,100	-43%	-$4.58M	0.71%	38
2022 Q2	$12.8M	Buy	+1,525,363	New	+$21.3M	1.65%	21
2020 Q4	–	Sell	-50,489	Closed	-$785K	–	77
2020 Q3	$785K	Sell	50,489 -242,211	-83%	-$4.17M	0.21%	64
2020 Q2	$5.35M	Buy	+292,700	New	+$5.16M	1.74%	21

Other funds holding BHC

Icahn Carl Sunny Isles Beach, Florida $8.26B AUM 15.11% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.72B AUM 1.39% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

ING Group Amsterdam, Netherlands $20.5B AUM 49.71% 1-Year Est. Return

MMA

Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return

Clearline Capital's BHC Position: Q3 2024 in Review

Clearline Capital sold out of Bausch Health (BHC) in Q3 2024, closing a stake of 987,206 shares — an estimated $6.88M sold.

Clearline Capital first reported a position in BHC in Q2 2020 and held it in 10 quarters. The position peaked at $12.8M in Q2 2022. 211 funds tracked by Wall St. Rank hold BHC as of Q3 2024.

Clearline Capital reported no remaining Bausch Health position as of Q3 2024 after selling out during the quarter.
Clearline Capital sold 987,206 Bausch Health shares in Q3 2024, an estimated $6.88M.
Clearline Capital first reported a position in Bausch Health in Q2 2020 and held it in 10 quarters.
Clearline Capital's Bausch Health position peaked at $12.8M in Q2 2022.
211 funds tracked by Wall St. Rank held Bausch Health as of Q3 2024.

Based on Clearline Capital's 13F filing for Q3 2024, filed 14 Nov 2024.